Skip to content

Investigator

Jian Zhang

Z BIOTECH, LLC · funded by NIGMS, NIBIB

Companies
1

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$1.6M

Summed across those awards.

First award
Apr 1, 2021

Latest Sep 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Development of TACA Glycan Library and Related Glycomics Products

    $314k

    Sep 1, 2025NIGMSZ BIOTECH, LLCNIH RePORTER · 11252818 (opens the source filing in a new tab)

  2. R43

    Development and Commercialization of Sialoglycan-Recognizing Probes

    $307k

    Sep 1, 2025NIGMSZ BIOTECH, LLCNIH RePORTER · 11183088 (opens the source filing in a new tab)

  3. R35

    Investigating the mechanobiology of multicellular morphogenesis

    $365k

    Sep 1, 2025NIGMSUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11022210 (opens the source filing in a new tab)

  4. R35

    Investigating the mechanobiology of multicellular morphogenesis

    $365k

    Sep 1, 2025NIGMSUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11384280 (opens the source filing in a new tab)

  5. R21

    Sorting and characterization of mechanically heterogeneous cell populations based on cellular contractility

    $182k

    Aug 1, 2023NIBIBUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11140434 (opens the source filing in a new tab)

  6. P20

    Investigating the bioenergetics of tumor cell clustering and cell-cell interactions

    $88k

    Apr 1, 2021NIGMSUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11137554 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources